Preoperative CRP may predict postoperative survival in patients with gastrointestinal tumors: Study Medha Baranwal10 Nov 2021 3:30 AM GMTChina: C-reactive protein/albumin ratio (CAR) is linked to poor survival in surgically treated gastrointestinal stromal tumors (GISTs) patients,...
FDA approves ripretinib for GI stromal tumors resistant to other kinase inhibitors Dr. Kamal Kant Kohli15 May 2020 11:27 PM GMTThe U.S. Food and Drug Administration has approved Qinlock (ripretinib) tablets as the first new drug specifically approved as a fourth-line treatment...
